vimarsana.com
Home
Live Updates
Personalis, National Cancer Center Hospital East, and Ono Collaborate to Better Predict Immunotherapy Response for Rectal Cancer : vimarsana.com
Personalis, National Cancer Center Hospital East, and Ono Collaborate to Better Predict Immunotherapy Response for Rectal Cancer
Multicenter VOLTAGE-2 Phase II Trial Will Conduct Exploratory Biomarker Analysis Using Highly-Sensitive Genomic Platforms from Personalis
... | May 16, 2023
Related Keywords
Fremont ,
California ,
United States ,
Richard Chen ,
Hideaki Bando ,
National Cancer Center Hospital East ,
Research Secretariat ,
Linkedin ,
Department Of Gastroenterology ,
National Cancer Center ,
Nasdaq ,
Twitter ,
Ono Pharmaceutical Co Ltd ,
Personalis Inc ,
Personalis Immuno ,
Executive Vice President ,
Chief Medical Officer ,
Assistant Chief ,
Principal Investigator ,
Personalis ,
Nc Stock Exchange ,
News ,
Information ,
Press Release ,
Multicenter ,
Hase ,
Hi ,
Trial ,
Hill ,
Conduct ,
Exploratory ,
Biomarker ,
Analysis ,
Sing ,
Enomic ,
Platforms ,
Rom Psnl Us71535d1063 ,
vimarsana.com © 2020. All Rights Reserved.